Response: We thank commenters for their feedback, and we point commenters to section III.F.4.b.(1)(a) of this final rule and reiterate that maintaining this 5,000-assigned beneficiary minimum for BY3 using the most recent data available prior to an ACO entering an agreement period maximizes the goals and benefit of the Shared Savings Program
No, Mounjaro (tirzepatide) is not licensed or approved for treating rheumatoid arthritis
Compounded medications are prepared by licensed pharmacies pursuant to a valid prescription
Practical strategies for lasting change Practice mindful eating at every meal
The efficacy and safety of Wegovy for its new indication underwent rigorous evaluation in a multi-national, multi-center, placebo-controlled double-blind trial encompassing over 17,600 participants
If your laboratory demands absolute reliability, our elite formulations will ensure your baseline data remains flawless and untainted by synthetic errors
